By Professor David Goldstein

Journal articles

Berania I; Tzelnick S; de Almeida JR; McKinnon G; Goldstein DP, 2023, 'Practice patterns for positive sentinel lymph node in head and neck melanoma', Head and Neck, 45, pp. 555 - 560, http://dx.doi.org/10.1002/hed.27262

Pavlakis N; Shitara K; Sjoquist KM; Martin AJ; Jaworski A; Yip S; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Strickland A; Rha SY; Lee K-W; Zalcberg JR; Price TJ; Simes J; Goldstein D, 2023, 'INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG).', Journal of Clinical Oncology, 41, pp. LBA294 - LBA294, http://dx.doi.org/10.1200/jco.2023.41.4_suppl.lba294

Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x

Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB, 2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074

Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB, 2023, 'Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy', Asia-Pacific Journal of Clinical Oncology, 19, pp. 243 - 249, http://dx.doi.org/10.1111/ajco.13834

Lemech C; Dredge K; Bampton D; Hammond E; Clouston A; Waterhouse NJ; Stanley AC; Leveque-El Mouttie L; Chojnowski GM; Haydon A; Pavlakis N; Burge M; Brown MP; Goldstein D, 2023, 'Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors', Journal for ImmunoTherapy of Cancer, 11, http://dx.doi.org/10.1136/jitc-2022-006136

De Guzman RB; Chua MLK; Goldstein D; Aung S; Eaton V; Park K, 2023, 'ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific', JCO Global Oncology, 9, http://dx.doi.org/10.1200/GO.22.00313

de Oliveira Faria S; Hueniken K; Kunaratnam V; Hui Huang S; Goldstein D; Ringash J; Pun J; Hope A; Spreafico A; Xu W; Howell D; Liu G, 2023, 'Associations between Human Papillomavirus Status, Weight Change, and Survival of Oropharyngeal Cancer Patients', Nutrition and Cancer, 75, pp. 1541 - 1550, http://dx.doi.org/10.1080/01635581.2023.2212427

Bonazzi VF; Aoude LG; Brosda S; Bradford JJ; Lonie JM; Loffler KA; Gartside MG; Patel K; Mukhopadhyay P; Keane C; Gebski V; Kench JG; Goldstein D; Waddell N; Barbour AP, 2023, 'C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients', Asia-Pacific Journal of Clinical Oncology, http://dx.doi.org/10.1111/ajco.13993

Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M, 2022, 'Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1060957

Mahfouz FM; Park SB; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; King T; Goldstein D; Mizrahi D, 2022, 'Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients', Clinical Autonomic Research, 32, pp. 497 - 506, http://dx.doi.org/10.1007/s10286-022-00895-w

Siu DHW; Ali A; Tjokrowidjaja A; De Silva M; Lee J; Clingan PR; Aghmesheh M; Brungs D; Mapagu C; Goldstein D; O'Neill S; Liauw WS; Sjoquist KM; Thomas D; Pavlakis N; Clarke SJ; Diakos C; Chantrill LA, 2022, 'Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers', Asia-Pacific Journal of Clinical Oncology, 18, pp. 660 - 668, http://dx.doi.org/10.1111/ajco.13745

Hooshmand K; Goldstein D; Timmins HC; Li T; Harrison M; Friedlander ML; Lewis CR; Lees JG; Moalem-Taylor G; Guennewig B; Park SB; Kwok JB, 2022, 'Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study', Journal of Translational Medicine, 20, http://dx.doi.org/10.1186/s12967-022-03754-4

Chiang JCB; Khou V; Tavakoli A; Park SB; Goldstein D; Krishnan AV; Markoulli M, 2022, 'Reproducibility and Reliability of Subbasal Corneal Nerve Parameters of the Inferior Whorl in the Neurotoxic and Healthy Cornea', Cornea, 41, pp. 1487 - 1494, http://dx.doi.org/10.1097/ICO.0000000000002947

Kokkinos J; Sharbeen G; Youkhana J; Boyer C; Goldstein D; Haghighi KS; McCarroll JA; Phillips PA, 2022, 'Abstract B076: βIII-Tubulin is a brake on extrinsic cell-death in pancreatic cancer', Cancer Research, 82, pp. B076 - B076, http://dx.doi.org/10.1158/1538-7445.panca22-b076

Kokkinos J; Sharbeen G; Haghighi KS; Youkhana J; Raina A; Pitiyarachchi O; Truong Q; Wenholz D; Laczka O; Kumar N; Goldstein D; Phillips PA, 2022, 'Abstract C073: CRO-67 is a novel therapeutic for pancreatic cancer: Implications for tumor and stromal reprogramming', Cancer Research, 82, pp. C073 - C073, http://dx.doi.org/10.1158/1538-7445.panca22-c073

Li T; Park SB; Battaglini E; King MT; Kiernan MC; Goldstein D; Rutherford C, 2022, 'Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use', Quality of Life Research, 31, pp. 3091 - 3107, http://dx.doi.org/10.1007/s11136-022-03154-7

Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2022, 'Tear film substance P in patients treated with neurotoxic chemotherapy', Experimental Eye Research, 224, http://dx.doi.org/10.1016/j.exer.2022.109253

Mcnamara MG; Bridgewater J; Goyal L; Jacobs T; Wagner AD; Goldstein D; Shroff R; Moehler M; Lowery M; Bekaii-Saab T; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox J; Valle J, 2022, 'What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-064954

Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P, 2022, 'Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study', Supportive Care in Cancer, 30, pp. 8201 - 8210, http://dx.doi.org/10.1007/s00520-022-07272-3

Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, 30, pp. 5965 - 5974, http://dx.doi.org/10.1007/s00520-022-07024-3

Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM, 2022, 'Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients', Patient Education and Counseling, 105, pp. 2206 - 2216, http://dx.doi.org/10.1016/j.pec.2022.01.011

Krasovitsky MS; Goldstein D, 2022, 'Destructive soft tissue metastases in advanced colorectal cancer: a case report', Annals of Palliative Medicine, 11, pp. 2170 - 2174, http://dx.doi.org/10.21037/apm-21-362

Maharaj AD; Evans SM; Ioannou LJ; Croagh D; Earnest A; Holland JF; Pilgrim CHC; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Burmeister EA; Evans PM; Hayes TM; Houli N; Knowles B; Leong T; Nikfarjam M; Philip J; Quinn M; Shapiro J; Smith MD; Spillane JB; Wong R; Zalcberg JR, 2022, 'The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer', HPB, 24, pp. 950 - 962, http://dx.doi.org/10.1016/j.hpb.2021.11.005

Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y

Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C, 2022, 'Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: A scoping review', Personalized Medicine, 19, pp. 139 - 153, http://dx.doi.org/10.2217/pme-2021-0096

Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC; Young M-A, 2022, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics, Part A, 188, pp. 725 - 734, http://dx.doi.org/10.1002/ajmg.a.62563

Foo T; Goldstein D; Segelov E; Shapiro J; Pavlakis N; Desai J; Yip D; Zalcberg J; Price TJ; Nagrial A; Chantrill L; Burge M; Karapetis CS; Tebbutt N; Roy AC, 2022, 'The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours', Targeted Oncology, 17, pp. 95 - 110, http://dx.doi.org/10.1007/s11523-022-00869-y

Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2022, 'Corrigendum to “Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy” [Gait Posture 89 (2021) 178–185](S0966636221002514)(10.1016/j.gaitpost.2021.07.010)', Gait and Posture, 92, pp. 1, http://dx.doi.org/10.1016/j.gaitpost.2021.11.006

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2022, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, 105, pp. 452 - 459, http://dx.doi.org/10.1016/j.pec.2021.05.018

Pavlakis N; Shitara K; Sjoquist KM; Martin AJ; Jaworski A; Yip S; Oh D-Y; Moehler MH; Bekaii-Saab TS; Simes J; Goldstein D, 2022, 'INTEGRATE IIb: A randomized phase III open label study of regorafenib + nivolumab versus standard chemotherapy in refractory advanced gastroesophageal cancer (AGOC).', Journal of Clinical Oncology, 40, pp. TPS366 - TPS366, http://dx.doi.org/10.1200/jco.2022.40.4_suppl.tps366

Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2022, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, 31, pp. 96 - 108, http://dx.doi.org/10.1002/jgc4.1455

Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G, 2022, 'Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice', Pain, 163, pp. 110 - 124, http://dx.doi.org/10.1097/j.pain.0000000000002384

Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2022, 'Psychological Outcomes in Advanced Cancer Patients After Receiving Genomic Tumor Profiling Results', Health Psychology, 41, pp. 396 - 408, http://dx.doi.org/10.1037/hea0001181

Chiang JCB; Krishnan AV; Goldstein D; Markoulli M, 2022, 'The Impact of Post-Tear Collection Storage on Tear Film Substance P Concentration', Current Eye Research, 47, pp. 1116 - 1120, http://dx.doi.org/10.1080/02713683.2022.2067565

Nguyen M; Segelov E; Goldstein D; Pavlakis N; Shapiro J; Price TJ; Nagrial A; Chantrill L; Leong T; Chen J; Burge M; Karapetis CS; Chau I; Lordick F; Renouf D; Tebbutt N; Roy AC, 2022, 'Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, 22, pp. 39 - 51, http://dx.doi.org/10.1080/14737140.2022.2002689

Perez-Concha O; Goldstein D; Harris MF; Laaksonen MA; Hanly M; Suchy S; Vajdic CM, 2022, 'Uptake of Team Care Arrangements for adults newly diagnosed with cancer', Australian Journal of Primary Health, 29, pp. 20 - 29, http://dx.doi.org/10.1071/py22078

Lundy J; Harris M; Zalcberg J; Zimet A; Goldstein D; Gebski V; Borsaru A; Desmond C; Swan M; Jenkins BJ; Croagh D, 2021, 'EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy', Frontiers in Oncology, 11, pp. 770022, http://dx.doi.org/10.3389/fonc.2021.770022

Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer', Scientific Reports, 11, pp. 1786, http://dx.doi.org/10.1038/s41598-021-81398-y

Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D, 2021, 'AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08666-y

Chiang JCB; Goldstein D; Tavakoli A; Trinh T; Klisser J; Lewis CR; Friedlander M; Naduvilath TJ; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel', Scientific Reports, 11, pp. 22884, http://dx.doi.org/10.1038/s41598-021-02439-0

Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0

Yu A; Street D; Viney R; Goodall S; Pearce A; Haywood P; Haas M; Battaglini E; Goldstein D; Timmins H; Park SB, 2021, 'Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences', Supportive Care in Cancer, 29, pp. 6379 - 6387, http://dx.doi.org/10.1007/s00520-021-06196-8

Aughton K; Elander NO; Evans A; Jackson R; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; Carter R; Cunningham D; Tebbutt NC; Goldstein D; Shannon J; Glimelius B; Hackert T; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Palmer DH; Büchler MW; Ghaneh P; Neoptolemos JP; Greenhalf W, 2021, 'HENT1 predicts benefit from gemcitabine in pancreatic cancer but only with low CDA mRNA', Cancers, 13, pp. 5758, http://dx.doi.org/10.3390/cancers13225758

Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho-Oncology, 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764

Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M, 2021, 'The experiences and needs of australian medical oncologists in integrating comprehensive genomic profiling into clinical care: A nation-wide survey', Oncotarget, 12, pp. 2169 - 2176, http://dx.doi.org/10.18632/ONCOTARGET.28076

Maharaj AD; Evans SM; Zalcberg JR; Ioannou LJ; Graco M; Croagh D; Pilgrim CHC; Dodson T; Goldstein D; Philip J; Kench JG; Merrett ND; Neale RE; White K; Evans P; Leong T, 2021, 'Barriers and enablers to the implementation of multidisciplinary team meetings: A qualitative study using the theoretical domains framework', BMJ Quality and Safety, 30, pp. 792 - 803, http://dx.doi.org/10.1136/bmjqs-2020-011793

Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6

Clifford BK; Jones MD; Simar D; Barry BK; Goldstein D, 2021, 'The effect of exercise intensity on exercise-induced hypoalgesia in cancer survivors: A randomized crossover trial', Physiological Reports, 9, pp. e15047, http://dx.doi.org/10.14814/phy2.15047

Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2021, 'Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy', Gait and Posture, 89, pp. 178 - 185, http://dx.doi.org/10.1016/j.gaitpost.2021.07.010

Back to profile page